Cancer

Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing…

1 month ago

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a…

1 month ago

Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of…

1 month ago

Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026

COVINGTON, Ky., Jan. 6, 2026 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic…

1 month ago

St. Baldrick’s Foundation Announces 2026 Ambassadors

Los Angeles, California--(Newsfile Corp. - January 6, 2026) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer…

1 month ago

Primefocus Health and Marshall Health Network Extend Collaboration to Support Breast Cancer Clinic

Strong Engagement and Improved Outcomes in Initial Pilot Program Demonstrate Potential for Providing Effective Remote Care for Breast CancerHUNTINGTON, W. Va.…

1 month ago

JOURNAL OF TRANSLATIONAL MEDICINE PUBLISHES PAPER HIGHLIGHTING POTENTIAL OF THE ELEPHAS LIVE™ PLATFORM TO TRANSFORM IMMUNOTHERAPY OUTCOMES

 Innovative Platform Aims to Boost Response Rates and Improve Lives of Cancer PatientsMADISON, Wis., Jan. 6, 2026 /PRNewswire/ -- Elephas…

1 month ago

NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio

FORT WORTH, Texas, Jan. 6, 2026 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John…

1 month ago

Base Molecular Resonance™ Technologies (BMRT) Achieves Historic Results in U.S. Government Sponsored Test

STUART, Fla., Jan. 6, 2026 /PRNewswire/ -- Base Molecular Resonance™ Technologies (BMRT) today announced the successful completion of a multi-day test supporting…

1 month ago

Behind the Relapse No One Saw Coming: How First Ascent Biomedical Is Changing Cancer Treatment Decisions

Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine…

1 month ago